AS
Live price temporarily unavailable.
Price history
Assembly Biosciences (ASMB) is a Health Care company in the Russell 2000. Latest news and coverage below.
Assembly Biosciences revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $0 | $9.02M | $14.8M | $16.0M | $79.1M | $6.25M | $0 | $7.16M | $28.5M | $72.3M |
| Growth (year over year) | — | — | +64.1% | +7.8% | +395.6% | −92.1% | −100.0% | — | +298.2% | +153.5% |
| Operating income | −$45.3M | −$52.2M | −$92.7M | −$102.7M | −$64.8M | −$132.7M | −$94.1M | −$64.6M | −$45.4M | −$12.1M |
| Operating margin | — | −579.1% | −626.4% | −643.4% | −81.9% | −2121.7% | — | −902.5% | −159.3% | −16.8% |
| Net income | −$44.3M | −$42.8M | −$90.8M | −$97.6M | −$62.2M | −$129.9M | −$93.1M | −$61.2M | −$40.2M | −$6.12M |
| Net margin | — | −474.7% | −613.0% | −611.6% | −78.6% | −2076.4% | — | −854.8% | −140.9% | −8.5% |
| EPS (diluted) | −$370.08 | −$347.04 | −$573.12 | −$535.68 | −$252.00 | −$36.00 | −$23.08 | −$13.38 | −$6.69 | −$0.55 |
| Balance sheet | ||||||||||
| Cash and equivalents | $28.6M | $82.0M | $41.5M | $46.7M | $59.4M | $45.6M | $52.4M | $19.8M | $38.3M | $58.5M |
| Total assets | $98.1M | $169.3M | $268.0M | $339.9M | $283.3M | $191.1M | $101.8M | $136.8M | $119.2M | $257.6M |
| Total liabilities | $18.2M | $56.2M | $57.4M | $66.7M | $42.7M | $22.1M | $19.1M | $95.7M | $85.8M | $50.8M |
| Shareholders' equity | $79.9M | $113.1M | $210.7M | $273.2M | $240.6M | $168.9M | $82.7M | $41.1M | $33.4M | $206.8M |
| Cash flow | ||||||||||
| Operating cash flow | −$34.9M | $1.86M | −$65.0M | −$84.1M | −$63.0M | −$93.4M | −$84.5M | $22.7M | −$51.1M | −$41.1M |
| Capital expenditure | $147.0K | $865.0K | $340.0K | $1.55M | $470.0K | $3.10M | $102.0K | $255.0K | $28.0K | $66.0K |
| Free cash flow | −$35.0M | $995.0K | −$65.3M | −$85.6M | −$63.4M | −$96.5M | −$84.6M | $22.5M | −$51.1M | −$41.2M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $6.84M | $7.36M | $9.42M | $9.63M | $10.8M | — | $8.21M | $13.4M |
| Growth (year over year) | — | — | +62.8% | +12.8% | +57.6% | — | −12.8% | +38.9% |
| Operating income | −$11.0M | −$11.5M | −$9.94M | −$11.1M | −$10.9M | — | −$11.4M | −$6.34M |
| Operating margin | −160.1% | −156.7% | −105.5% | −115.2% | −100.9% | — | −138.4% | −47.4% |
| Net income | −$9.61M | −$10.3M | −$8.82M | −$10.2M | −$9.20M | — | −$9.08M | −$3.86M |
| Net margin | −140.4% | −140.5% | −93.6% | −105.9% | −85.2% | — | −110.5% | −28.8% |
| EPS (diluted) | −$1.51 | −$1.54 | −$1.17 | −$1.33 | −$0.72 | — | −$0.54 | −$0.20 |
| Balance sheet | ||||||||
| Cash and equivalents | $28.5M | $38.3M | $23.4M | $24.0M | $22.5M | $58.5M | $31.1M | $32.3M |
| Total assets | $100.3M | $119.2M | $99.0M | $80.8M | $240.0M | $257.6M | $235.5M | $330.8M |
| Total liabilities | $74.3M | $85.8M | $71.9M | $62.7M | $57.3M | $50.8M | $36.9M | $25.2M |
| Shareholders' equity | $26.0M | $33.4M | $27.1M | $18.1M | $182.7M | $206.8M | $198.6M | $305.6M |
| Cash flow | ||||||||
| Operating cash flow | −$15.2M | −$407.0K | −$23.4M | −$16.8M | −$15.1M | — | −$22.1M | −$15.5M |
| Capital expenditure | $0 | $0 | $0 | $0 | $42.0K | — | $19.0K | $0 |
| Free cash flow | −$15.2M | −$407.0K | −$23.4M | −$16.8M | −$15.2M | — | −$22.1M | −$15.5M |
From Assembly Biosciences's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Assembly Biosciences
- Headquarters
- South San Francisco, California From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International